Otherwise, the effects might be tissue-dependent, as very high GIPR levels in neuroendocrine tumors have been observed to either increase or decrease raised proliferation levels, depending on the tumor site [39,40]. This evidence concerns the gene GIPR and neuroendocrine neoplasm.